Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Association of glycemic variability and time in range with lipid profile in type 1 diabetes.Endocrine · 2024
   Article
2. Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus.Cardiovascular diabetology · 2022
   Article
3. International Consensus on Use of Continuous Glucose Monitoring.Diabetes care · 2017
   Review
4. Response to comment on: Statin use and risk of diabetes mellitus.World journal of diabetes · 2016
   Article
5. Antioxidant status in patients with acute myocardial infarction.Indian journal of clinical biochemistry : IJCB · 2007
   Article
6. Prediabetes mellitus and its links to atherosclerosis.Current diabetes reports · 2003
   Review
7. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?BMJ (Clinical research ed.) · 2002
   Review
8. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes.Current atherosclerosis reports · 2002
   Review
9. Insulin resistance and vessel endothelial function.Journal of the Royal Society of Medicine · 2002
   Review

Corrections and comments

• Comment on
  Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.2001

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as